156 related articles for article (PubMed ID: 5025912)
21. Prediction of diuretic mobilization of cirrhotic ascites by pretreatment fractional sodium excretion.
Knauf H; Wenk E; Schölmerich J; Goerg KJ; Gerok W; Leser HG; Mutschler E
Klin Wochenschr; 1990 Jun; 68(11):545-51. PubMed ID: 2198378
[TBL] [Abstract][Full Text] [Related]
22. [Influence of diuretics on the survival of 180 patients with cirrhosis of the liver and ascites].
Robert M; Portmann B
Schweiz Med Wochenschr; 1969 Feb; 99(6):178-82. PubMed ID: 5781367
[No Abstract] [Full Text] [Related]
23. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].
Traina M; Vizzini GB
Minerva Med; 1986 Jan; 77(3-4):87-91. PubMed ID: 3511409
[TBL] [Abstract][Full Text] [Related]
24. [Management of hepatic ascites using Fursemide].
Bemvenuti GA; Job JM
Hospital (Rio J); 1968 Nov; 74(5):1601-38. PubMed ID: 5305338
[No Abstract] [Full Text] [Related]
25. Spironolactone diuresis in patients with cirrhosis and ascites.
Eggert RC
Br Med J; 1970 Nov; 4(5732):401-3. PubMed ID: 5481518
[TBL] [Abstract][Full Text] [Related]
26. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
[TBL] [Abstract][Full Text] [Related]
27. Use of diuretics in the treatment of cirrhotic ascites.
Boyer TD; Warnock DG
Gastroenterology; 1983 May; 84(5 Pt 1):1051-5. PubMed ID: 6832557
[No Abstract] [Full Text] [Related]
28. [Value of the association of a certain dose of spironolactone with a sulfamide diuretic in the treatment of ascitic cirrhosis].
Brette R; Pasquier J; Mestrallet G; Olivier L
Sem Ther; 1964 Jan; 40(1):34-40. PubMed ID: 5878908
[No Abstract] [Full Text] [Related]
29. The impact of diuretics on chronic liver disease.
Steigmann F; Mejicano R
Am J Gastroenterol; 1969 Jul; 52(1):37-44. PubMed ID: 5796683
[No Abstract] [Full Text] [Related]
30. [Hyperaldosteronism, spironolactone and liver cirrhosis].
Sort P; Guevara M; Arroyo V
Gastroenterol Hepatol; 1997 Mar; 20(3):151-9. PubMed ID: 9162537
[No Abstract] [Full Text] [Related]
31. [Diuretic treatment of hepatic cirrhosis: use of distal diuretics].
Escartin Marín P; Arenas Mirave I; Alvarez Bustos G; Arenas de Pablo A; García Plaza A
Rev Clin Esp; 1974 Jan; 132(1):65-70. PubMed ID: 4840230
[No Abstract] [Full Text] [Related]
32. [Controlled clinical study of the effect of combined administration of ethacrynic acid and spironolactone in ascitic liver cirrhosis].
Marra N; Micheli E; Spagnolo G
Clin Ter; 1979 Jul; 90(2):143-63. PubMed ID: 527296
[No Abstract] [Full Text] [Related]
33. [Contribution to the study of the treatment of the ascitic syndrome of cirrhosis by the combination of spironolactone and sulfonamide diuretic. Initial therapy and supportive therapy. Apropos of 55 cases].
Fraisse H; Perret M; Etaix JP
J Med Lyon; 1967 Feb; 48(114):173-83. PubMed ID: 5600100
[No Abstract] [Full Text] [Related]
34. [Conservative treatment of ascites in patients with cirrhosis of the liver].
Hartleb J; Mazur W
Wiad Lek; 1989 Aug 15-Sep 15; 42(16-18):1000-5. PubMed ID: 2640068
[No Abstract] [Full Text] [Related]
35. [Use of Aldactone in a patient with ascitic form of liver cirrhosis].
Zinkevich SV
Pediatr Akus Ginekol; 1968; 3():25-6. PubMed ID: 5717821
[No Abstract] [Full Text] [Related]
36. [Comparative study of diuretic drugs used in cirrhotic and ascitic patients].
Lennhoff M; Duhalt R; Peña JC
Rev Invest Clin; 1968; 20(2):165-80. PubMed ID: 5721631
[No Abstract] [Full Text] [Related]
37. [Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts].
Vesin P
Schweiz Med Wochenschr; 1971 Mar; 101(11):398-401. PubMed ID: 5558553
[No Abstract] [Full Text] [Related]
38. Diuresis in the ascitic patient: a randomized controlled trial of three regimens.
Fogel MR; Sawhney VK; Neal EA; Miller RG; Knauer CM; Gregory PB
J Clin Gastroenterol; 1981; 3 Suppl 1():73-80. PubMed ID: 7035545
[TBL] [Abstract][Full Text] [Related]
39. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
Tempini S; Bellati G; Ideo G
Minerva Dietol Gastroenterol; 1984; 30(3):255-61. PubMed ID: 6504374
[No Abstract] [Full Text] [Related]
40. Liver: diuretic agents for ascites: joining forces from the start?
Ginès P
Nat Rev Gastroenterol Hepatol; 2010 Jun; 7(6):310-1. PubMed ID: 20523351
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
